480450-89-3 Usage
Uses
Used in Pharmaceutical Industry:
1H-Indole-2-carboxylic acid, 5-chloro-4-fluoro-, methyl ester is used as a building block for the synthesis of pharmaceutical compounds and research chemicals due to its versatile chemical structure and biological activities.
Used in Anti-cancer Applications:
1H-Indole-2-carboxylic acid, 5-chloro-4-fluoro-, methyl ester is used as an anti-cancer agent for its potential therapeutic applications in treating various types of cancer.
Used in Anti-inflammatory Applications:
1H-Indole-2-carboxylic acid, 5-chloro-4-fluoro-, methyl ester is used as an anti-inflammatory agent for its potential therapeutic applications in reducing inflammation and related conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 480450-89-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 4,8,0,4,5 and 0 respectively; the second part has 2 digits, 8 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 480450-89:
(8*4)+(7*8)+(6*0)+(5*4)+(4*5)+(3*0)+(2*8)+(1*9)=153
153 % 10 = 3
So 480450-89-3 is a valid CAS Registry Number.
480450-89-3Relevant academic research and scientific papers
Diamine derivatives
-
, (2008/06/13)
A compound represented by the general formula (1): Q1-Q2-T0-N(R1)-Q3-N(R2)-T1-Q4??(1) wherein R1 and R2 are hydrogen atoms or the like; Q1 is a saturated or unsaturated, 5- or 6-membered cyclic hydrocarbon group which may be substituted, or the like; Q2 is a single bond or the like; Q3 is a group in which Q5 is an alkylene group having 1 to 8 carbon atoms, or the like; and T0 and T1 are carbonyl groups or the like; a salt thereof, a solvate thereof, or an N-oxide thereof. The compound is useful as an agent for preventing and/or treating cerebral infarction, cerebral embolism, myocardial infarction, angina pectoris, pulmonary infarction, pulmonary embolism, Buerger's disease, deep venous thrombosis, disseminated intravascular coagulation syndrome, thrombus formation after valve or joint replacement, thrombus formation and reocclusion after angioplasty, systemic inflammatory response syndrome (SIRS), multiple organ dysfunction syndrome (MODS), thrombus formation during extracorporeal circulation, or blood clotting upon blood drawing.
